Study ID: Sanofi Pasteur H-030-014 C Diff Vaccine
Title:

Protocol H-030-014 is a planned Phase III Study of C. difficile vaccine in participants at risk for C. difficile Infection = 50 years of age.

Location:
Fargo Region
Principal Investigator:
Paul Mariani MD
Disease:
Stage:
Phase III

Status:

Active - Open to Accrual

For more information, call or email Bismarck Clinical Research at (701) 323-5760, Fargo and Bemidji Clinical Research at (701) 234-5890, or Sioux Falls Clinical Research at (605) 328-1368.

Back to Clinical Trials list